Insider Trading: Optimer Pharmaceuticals Inc (OPTR.O)

OPTR.O on Nasdaq

14.84USD
10:01am EDT
Price Change (% chg)

$0.14 (+0.95%)
Prev Close
$14.97
Open
$14.75
Day's High
$14.93
Day's Low
$14.66
Volume
92,638
Avg. Vol
1,009,343
52-wk High
$16.80
52-wk Low
$8.64

Search Stocks
CHANG MICHAEL N Options Exercised: 0
Trade Date: Saturday, 31 Dec 2011 Price: 0.00
Title: Director Shares Held: 821,402
Type Traded: Direct Net Change in Shares This Filing: 5,000

Institutional Holders

% Shares Owned: 90.50%
# of Holders: 134
Total Shares Held: 44,091,156
3 Mo. Net Change: 2,145,365
# New Positions: 20
# Closed Positions: 18
# Increased Positions: 61
# Reduced Positions: 54
# Net Buyers: 7

Officers & Directors

Name Age Since Current Position

Henry McKinnell

70 2013 Chairman of the Board, Chief Executive Officer

Stephen Webster

51 2012 Chief Financial Officer and Principal Financial and Accounting Officer

Eric Sirota

51 2013 Chief Operating Officer

Sherwood Gorbach

77 2011 Senior Vice President, Chief Scientific Officer

Linda Amper

55 2011 Senior Vice President - Human Resources

Meredith Schaum

2013 Chief Compliance Officer, General Counsel, Secretary

Mark Auerbach

2013 Lead Independent Director

Michael Chang

61 2012 Director

Stephen Newman

62 2012 Director

Anthony Altig

56 2007 Independent Director

Joseph Chang

60 2012 Independent Director

Peter Grebow

65 2009 Independent Director

Robert Zerbe

61 2009 Independent Director

David Walsey

VP - Investor Relations & Corporate Communications
Search Stocks